Literature DB >> 848804

Reversible hematologic sequelae of diabetes mellitus.

C M Peterson, R L Jones, R J Koenig, E T Melvin, M L Lehrman.   

Abstract

Seven patients with diabetes mellitus were hospitalized and their blood sugar concentrations regulated as a result of fasting blood sugar, sugar around meals, urinary sugar, and hemoglobin AIC assays. Erythrocyte half-life as measured by 51 Cr increased in all patients from a mean of 27 days to 31 days, while hemoglobin AIC levels decreased from a mean of 10.1% to 5.6%. Leukocyte adherence increased in all patients from a mean of 28% to 51%. Most striking were the changes observed in platelet function in response to epinephrine. The length of the secondary lag phase of platelet aggregation, after a stimulus with final concentration of 70 muM of epinephrine, increased from a mean of 19 seconds to 65 seconds. Studies in additional patients confirmed an inverse correlation between hemoglobin AIC concentration and the secondary lag phase (r = 0.87, P less than 0.001). These studies found that certain secondary sequelas of diabetes can be corrected by strict carbohydrate control and confirmed that hemoglobin AIC assays provide a useful means of showing the degree of control of glucose metabolism in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 848804     DOI: 10.7326/0003-4819-86-4-425

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  46 in total

1.  Glycosylated hemoglobins: a review.

Authors:  A A Nanji; M R Pudek
Journal:  Can Fam Physician       Date:  1983-03       Impact factor: 3.275

2.  A semi-mechanistic model of the relationship between average glucose and HbA1c in healthy and diabetic subjects.

Authors:  Rocío Lledó-García; Norman A Mazer; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-01-10       Impact factor: 2.745

3.  Modeling of red blood cell life-spans in hematologically normal populations.

Authors:  Rocío Lledó-García; Robert M Kalicki; Dominik E Uehlinger; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-07-31       Impact factor: 2.745

4.  Molecular basis for a link between complement and the vascular complications of diabetes.

Authors:  J Acosta; J Hettinga; R Flückiger; N Krumrei; A Goldfine; L Angarita; J Halperin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 5.  Haemoglobin A1 and diabetes mellitus.

Authors:  G Gonen; A H Rubenstein
Journal:  Diabetologia       Date:  1978-07       Impact factor: 10.122

6.  Studies of retinopathy and the plasma co-factor of platelet hyperaggregation in type 1 (insulin-dependent) diabetic children.

Authors:  R D Levin; H C Kwaan; J G Dobbie; C L Fetkenhour; H S Traisman; C Kramer
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

7.  Erythrocyte insulin receptor: normalization of binding data for the average cell age by the red cell creatine determination in obese, diabetic and acromegalic patients.

Authors:  A C Lerario; W el-Andere; B L Wajchenberg; L Y Ohnuma; M H Rocha; A Andriolo
Journal:  Acta Diabetol Lat       Date:  1988 Oct-Dec

8.  Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c.

Authors:  Robert M Cohen; Robert S Franco; Paramjit K Khera; Eric P Smith; Christopher J Lindsell; Peter J Ciraolo; Mary B Palascak; Clinton H Joiner
Journal:  Blood       Date:  2008-08-11       Impact factor: 22.113

9.  Noninvasive Blood and Tissue Analysis: Raman Spectroscopy, One Perspective for Monitoring of Glucose and Beyond.

Authors:  Joseph Chaiken; Charles M Peterson
Journal:  J Diabetes Sci Technol       Date:  2020-10-21

10.  Glycosylated hemoglobin in fractions of erythrocytes of different ages.

Authors:  C Krzisnik; J Lukac-Bajalo
Journal:  J Endocrinol Invest       Date:  1993 Jul-Aug       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.